DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE

DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE was reported 819 times

DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CATHETER SITE PARAESTHESIA 1 0.1000
1 HIATUS HERNIA STRANGULATED 1 0.0455
2 ALLERGY TO IMMUNOGLOBULIN THERAPY 3 0.0275
3 AUTOIMMUNE EYE DISORDER 1 0.0238
4 ATYPICAL MIGRAINE 1 0.0217
5 AMELOBLASTOMA 1 0.0189
6 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 1 0.0169
7 DYSANIA 1 0.0130
8 INTRAPARTUM HAEMORRHAGE 1 0.0125
9 ADMINISTRATION SITE INFECTION 1 0.0105
10 SECONDARY HYPERTHYROIDISM 1 0.0103
11 INCISION SITE CELLULITIS 1 0.0093
12 PRECANCEROUS LESION OF DIGESTIVE TRACT 1 0.0088
13 SEBACEOUS CARCINOMA 1 0.0087
14 ACHROMOBACTER INFECTION 1 0.0083
15 CONJUNCTIVAL EROSION 1 0.0083
16 BLEPHAROPLASTY 1 0.0082
17 INFUSION SITE SCAB 1 0.0081
18 ADMINISTRATION SITE IRRITATION 1 0.0071
19 NON-24-HOUR SLEEP-WAKE DISORDER 1 0.0071
20 SMOKE SENSITIVITY 2 0.0065
21 AORTIC VALVE THICKENING 1 0.0062
22 ENDOMETRIAL CANCER METASTATIC 1 0.0062
23 CATHETER SITE BRUISE 2 0.0060
24 LABELLED DRUG-FOOD INTERACTION ISSUE 1 0.0059
25 ATRIAL SEPTAL DEFECT REPAIR 1 0.0058
26 HANGNAIL 1 0.0058
27 PICA 1 0.0056
28 ANAL FISSURE HAEMORRHAGE 1 0.0054
29 INFUSION SITE NECROSIS 1 0.0052
30 LARYNGEAL PAIN 2 0.0049
31 BACTERIAL DIARRHOEA 1 0.0047
32 FEMALE REPRODUCTIVE TRACT DISORDER 1 0.0046
33 INFUSION SITE SCAR 2 0.0045
34 NECROTISING SOFT TISSUE INFECTION 1 0.0043
35 CLOSTRIDIAL SEPSIS 1 0.0041
36 INTESTINAL SEPSIS 1 0.0038
37 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
38 BACTERIAL VULVOVAGINITIS 1 0.0035
39 OESOPHAGEAL IRRITATION 2 0.0034
40 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
41 MITRAL VALVE THICKENING 1 0.0034
42 BUTTOCK INJURY 1 0.0033
43 STAPHYLOCOCCAL ABSCESS 2 0.0031
44 ANOREXIA NERVOSA 1 0.0031
45 ALCOHOL INTERACTION 6 0.0031
46 POST PROCEDURAL CONTUSION 1 0.0030
47 SARS-COV-2 TEST NEGATIVE 2 0.0030
48 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
49 JOINT ABSCESS 1 0.0029
50 MEDIAL TIBIAL STRESS SYNDROME 1 0.0029
51 INFUSION SITE DISCHARGE 5 0.0028
52 IMMUNISATION REACTION 2 0.0028
53 INFUSION SITE MASS 3 0.0028
54 PENILE ERYTHEMA 1 0.0027
55 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 1 0.0027
56 ABSCESS RUPTURE 1 0.0027
57 ANISOCORIA 1 0.0026
58 INFUSION SITE INFECTION 6 0.0026
59 FAT TISSUE DECREASED 1 0.0026
60 LUNG CYST 1 0.0025
61 CROUP INFECTIOUS 2 0.0025
62 AMMONIA ABNORMAL 1 0.0025
63 CLUBBING 1 0.0025
64 REACTION TO COLOURING 1 0.0024
65 MEDICAL INDUCTION OF COMA 1 0.0024
66 CAROTID ARTERY DISSECTION 1 0.0023
67 DEVICE LOOSENING 2 0.0023
68 HEART VALVE OPERATION 1 0.0023
69 INFUSION SITE DISCOLOURATION 2 0.0023
70 ENLARGED UVULA 1 0.0022
71 EATING DISORDER SYMPTOM 1 0.0022
72 EHLERS-DANLOS SYNDROME 1 0.0022
73 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
74 MASTOCYTOSIS 1 0.0021
75 BLOOD CREATINE ABNORMAL 1 0.0021
76 INFUSION SITE INDURATION 3 0.0020
77 BONE DEMINERALISATION 2 0.0019
78 BLOOD MAGNESIUM ABNORMAL 1 0.0018
79 CATHETER SITE DISCHARGE 2 0.0018
80 RENAL TUBULAR DYSFUNCTION 1 0.0018
81 HAEMATOCRIT INCREASED 4 0.0018
82 PROSTATECTOMY 1 0.0017
83 NEPHROGENIC ANAEMIA 8 0.0017
84 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
85 RENAL SURGERY 1 0.0015
86 CYST RUPTURE 1 0.0015
87 NASAL OPERATION 1 0.0015
88 CHRONIC FATIGUE SYNDROME 2 0.0014
89 FUNGAL OESOPHAGITIS 1 0.0014
90 GLASSY EYES 1 0.0014
91 GLUTEN SENSITIVITY 2 0.0014
92 CATHETER SITE ERYTHEMA 3 0.0014
93 ANTIBODY TEST ABNORMAL 1 0.0014
94 INFUSION SITE BRUISING 3 0.0014
95 REBOUND ACID HYPERSECRETION 4 0.0013
96 INFUSION SITE PAIN 17 0.0013
97 ARTHRITIS INFECTIVE 6 0.0013
98 DRUG TOLERANCE INCREASED 1 0.0013
99 EXTRADURAL ABSCESS 1 0.0013
100 PNEUMONIA MYCOPLASMAL 1 0.0013
101 PERIORBITAL HAEMATOMA 1 0.0012
102 DEVICE INFUSION ISSUE 3 0.0012
103 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
104 HYPERPARATHYROIDISM SECONDARY 3 0.0012
105 INFUSION SITE OEDEMA 1 0.0012
106 TYMPANIC MEMBRANE PERFORATION 2 0.0012
107 APTYALISM 1 0.0012
108 CRANIOFACIAL FRACTURE 1 0.0012
109 ALLERGIC SINUSITIS 1 0.0012
110 CATHETER SITE PAIN 3 0.0012
111 CATHETER SITE PRURITUS 1 0.0011
112 ABDOMINAL NEOPLASM 1 0.0011
113 IMPLANT SITE PRURITUS 1 0.0011
114 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
115 HAEMOGLOBIN INCREASED 5 0.0011
116 MUSCLE SWELLING 1 0.0011
117 BONE GRAFT 1 0.0011
118 CATHETER SITE SWELLING 1 0.0011
119 INFUSION SITE ERYTHEMA 9 0.0011
120 BONE CYST 1 0.0011
121 INJECTION SITE ULCER 1 0.0011
122 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
123 ANIMAL SCRATCH 1 0.0010
124 BLOOD IRON ABNORMAL 1 0.0010
125 DUST ALLERGY 1 0.0010
126 PYURIA 1 0.0010
127 CARDIAC ANEURYSM 1 0.0010
128 INFUSION SITE REACTION 3 0.0010
129 ANTISOCIAL BEHAVIOUR 1 0.0010
130 INFUSION SITE DISCOMFORT 1 0.0010
131 HYPOPERFUSION 1 0.0010
132 GASTRIC CANCER STAGE IV 2 0.0009
133 PRODUCT NAME CONFUSION 1 0.0009
134 INFUSION SITE HAEMORRHAGE 3 0.0009
135 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
136 AORTIC DILATATION 1 0.0009
137 ANHEDONIA 23 0.0009
138 INCISION SITE PAIN 1 0.0009
139 GROIN ABSCESS 1 0.0008
140 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
141 PNEUMONIA INFLUENZAL 1 0.0008
142 OXYGEN CONSUMPTION INCREASED 2 0.0008
143 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
144 INFUSION SITE WARMTH 1 0.0008
145 POST-ACUTE COVID-19 SYNDROME 1 0.0008
146 ECONOMIC PROBLEM 12 0.0008
147 SEROMA 1 0.0008
148 OVARIAN CYST RUPTURED 1 0.0008
149 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
150 END STAGE RENAL DISEASE 14 0.0008
151 MULTIPLE ALLERGIES 6 0.0008
152 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
153 WEIGHT BEARING DIFFICULTY 2 0.0007
154 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
155 IMPAIRED GASTRIC EMPTYING 10 0.0007
156 INFUSION SITE RASH 1 0.0007
157 INSURANCE ISSUE 11 0.0007
158 JOINT INSTABILITY 1 0.0007
159 PERIODONTAL DISEASE 1 0.0007
160 MAST CELL ACTIVATION SYNDROME 1 0.0007
161 PANCREATIC CARCINOMA METASTATIC 2 0.0007
162 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
163 ANKLE OPERATION 1 0.0007
164 EAR INFECTION 18 0.0007
165 NEPHRECTOMY 1 0.0007
166 HYPOSMIA 1 0.0007
167 CENTRAL VENOUS CATHETERISATION 2 0.0007
168 EPICONDYLITIS 1 0.0007
169 INTELLECTUAL DISABILITY 1 0.0007
170 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
171 POLYCYSTIC OVARIES 1 0.0006
172 BACTERIAL VAGINOSIS 1 0.0006
173 MEDICAL DEVICE IMPLANTATION 1 0.0006
174 SEASONAL ALLERGY 9 0.0006
175 INFUSION SITE PRURITUS 2 0.0006
176 INAPPROPRIATE AFFECT 1 0.0006
177 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
178 OXYGEN THERAPY 1 0.0006
179 INTESTINAL POLYP 1 0.0006
180 NEAR DEATH EXPERIENCE 2 0.0006
181 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
182 BLOOD CALCIUM ABNORMAL 1 0.0006
183 ENTEROBACTER INFECTION 1 0.0006
184 METASTASES TO SPINE 2 0.0006
185 OSTEOPENIA 9 0.0006
186 LACK OF INJECTION SITE ROTATION 1 0.0006
187 RESPIRATORY DEPRESSION 7 0.0006
188 BREAST DISCHARGE 1 0.0006
189 FANCONI SYNDROME ACQUIRED 1 0.0006
190 HEREDITARY ANGIOEDEMA 6 0.0006
191 GASTROINTESTINAL INFECTION 5 0.0006
192 DEVICE ALARM ISSUE 1 0.0006
193 BLOOD PHOSPHORUS DECREASED 2 0.0005
194 BODY TEMPERATURE ABNORMAL 1 0.0005
195 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
196 CHRONIC SINUSITIS 2 0.0005
197 CATHETER SITE INFECTION 2 0.0005
198 BONE MARROW TRANSPLANT 1 0.0005
199 CHRONIC KIDNEY DISEASE 40 0.0005
200 DERMATITIS CONTACT 6 0.0005
201 HYPERCOAGULATION 1 0.0005
202 ARTERIAL DISORDER 1 0.0005
203 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
204 RHEUMATIC DISORDER 1 0.0005
205 HYPOGEUSIA 1 0.0005
206 VULVOVAGINAL MYCOTIC INFECTION 2 0.0005
207 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0005
208 REBOUND ATOPIC DERMATITIS 1 0.0005
209 SPINAL STENOSIS 2 0.0005
210 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1 0.0005
211 CHEST INJURY 1 0.0005
212 IMPAIRED SELF-CARE 1 0.0005
213 INSULIN RESISTANCE 1 0.0005
214 EYE CONTUSION 1 0.0005
215 EAR SWELLING 1 0.0005
216 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
217 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
218 ABSCESS LIMB 2 0.0005
219 TENSION HEADACHE 2 0.0005
220 JAW FRACTURE 1 0.0005
221 PHARYNGITIS STREPTOCOCCAL 5 0.0005
222 RESPIRATORY TRACT INFECTION 12 0.0005
223 SKIN LACERATION 5 0.0005
224 ENDOMETRIAL CANCER 1 0.0005
225 DIABETIC NEPHROPATHY 1 0.0005
226 CATHETERISATION CARDIAC 2 0.0005
227 BONE DENSITY DECREASED 14 0.0004
228 INFECTIOUS MONONUCLEOSIS 1 0.0004
229 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
230 VASCULAR DEVICE INFECTION 2 0.0004
231 LYMPHOEDEMA 3 0.0004
232 SKIN ABRASION 2 0.0004
233 RADIUS FRACTURE 1 0.0004
234 VULVOVAGINAL PAIN 2 0.0004
235 LYMPHADENITIS 1 0.0004
236 HAEMATOLOGICAL INFECTION 1 0.0004
237 DERMAL CYST 1 0.0004
238 SENSITIVE SKIN 3 0.0004
239 ARTHROPOD BITE 3 0.0004
240 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
241 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
242 GASTROINTESTINAL TUBE INSERTION 1 0.0004
243 VEIN DISORDER 2 0.0004
244 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
245 LACTOSE INTOLERANCE 1 0.0004
246 MEAN CELL VOLUME INCREASED 1 0.0004
247 OSTEOPOROSIS 16 0.0004
248 FOOD ALLERGY 3 0.0004
249 GASTROENTERITIS VIRAL 7 0.0004
250 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
251 SENSITIVITY TO WEATHER CHANGE 2 0.0004
252 SCRATCH 4 0.0004
253 ABDOMINAL MASS 1 0.0004
254 BEHAVIOUR DISORDER 2 0.0004
255 FOOT FRACTURE 7 0.0004
256 EAR CONGESTION 1 0.0004
257 DECUBITUS ULCER 3 0.0004
258 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
259 LIP BLISTER 1 0.0004
260 GASTRIC PERFORATION 1 0.0004
261 WOUND INFECTION 4 0.0004
262 SPINAL COMPRESSION FRACTURE 3 0.0004
263 HYPERKERATOSIS 2 0.0004
264 CYSTIC FIBROSIS 2 0.0004
265 VIRAL INFECTION 12 0.0004
266 CHOLECYSTITIS INFECTIVE 1 0.0004
267 ELECTRIC SHOCK SENSATION 1 0.0004
268 ENDOTRACHEAL INTUBATION 1 0.0004
269 KIDNEY INFECTION 7 0.0004
270 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
271 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
272 OXYGEN SATURATION ABNORMAL 1 0.0004
273 OESOPHAGEAL STENOSIS 1 0.0004
274 SCAB 4 0.0004
275 MUSCULOSKELETAL DISCOMFORT 6 0.0003
276 EYELID MARGIN CRUSTING 1 0.0003
277 SKIN SWELLING 3 0.0003
278 DYSPNOEA AT REST 1 0.0003
279 INJECTION SITE VESICLES 2 0.0003
280 UROSEPSIS 3 0.0003
281 POOR QUALITY SLEEP 7 0.0003
282 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
283 DIASTOLIC DYSFUNCTION 1 0.0003
284 PRODUCT DISTRIBUTION ISSUE 3 0.0003
285 ILEUS 4 0.0003
286 INFUSION SITE EXTRAVASATION 2 0.0003
287 SWELLING OF EYELID 2 0.0003
288 INFUSION SITE SWELLING 2 0.0003
289 ORTHOPNOEA 1 0.0003
290 BACTERIAL SEPSIS 1 0.0003
291 MULTIPLE FRACTURES 5 0.0003
292 TOOTH INFECTION 4 0.0003
293 WALKING AID USER 2 0.0003
294 QUALITY OF LIFE DECREASED 4 0.0003
295 ECCHYMOSIS 2 0.0003
296 RIB FRACTURE 6 0.0003
297 WEIGHT FLUCTUATION 3 0.0003
298 MASS 4 0.0003
299 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
300 HAND FRACTURE 2 0.0003
301 THERMAL BURN 2 0.0003
302 GLOSSITIS 1 0.0003
303 APPENDICECTOMY 1 0.0003
304 DECREASED ACTIVITY 3 0.0003
305 PANIC REACTION 2 0.0003
306 RASH PUSTULAR 2 0.0003
307 DEVICE KINK 1 0.0003
308 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
309 DENTAL CARIES 3 0.0003
310 SUNBURN 2 0.0003
311 OCULAR DISCOMFORT 3 0.0003
312 EYE INFECTION 3 0.0003
313 PRODUCT STORAGE ISSUE 1 0.0003
314 PARANASAL SINUS HYPERSECRETION 1 0.0003
315 GASTRIC INFECTION 1 0.0003
316 CLAVICLE FRACTURE 1 0.0003
317 PROCEDURAL COMPLICATION 2 0.0003
318 OESOPHAGEAL DISORDER 1 0.0003
319 ANKLE FRACTURE 4 0.0003
320 PANIC DISORDER 1 0.0003
321 LIMB INJURY 7 0.0003
322 INFUSION RELATED REACTION 17 0.0003
323 ORAL INFECTION 1 0.0003
324 POLYDIPSIA 1 0.0003
325 INFLUENZA 28 0.0003
326 COVID-19 44 0.0003
327 HYPERPHAGIA 1 0.0003
328 OBSTRUCTION 1 0.0003
329 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
330 BLEPHARITIS 1 0.0002
331 FUNGAL SKIN INFECTION 1 0.0002
332 MYASTHENIA GRAVIS 2 0.0002
333 FEEDING DISORDER 5 0.0002
334 BACK DISORDER 4 0.0002
335 POST PROCEDURAL INFECTION 2 0.0002
336 ABNORMAL FAECES 2 0.0002
337 ARTHRITIS BACTERIAL 1 0.0002
338 SPINAL OPERATION 3 0.0002
339 TOOTH EXTRACTION 3 0.0002
340 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
341 DYSSTASIA 7 0.0002
342 AORTIC VALVE INCOMPETENCE 1 0.0002
343 SINUSITIS 24 0.0002
344 PURULENT DISCHARGE 1 0.0002
345 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
346 DEVICE OPERATIONAL ISSUE 1 0.0002
347 HIATUS HERNIA 3 0.0002
348 EMOTIONAL DISTRESS 28 0.0002
349 HORDEOLUM 1 0.0002
350 PLATELET COUNT INCREASED 3 0.0002
351 BONE CANCER 1 0.0002
352 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
353 IMMOBILE 1 0.0002
354 ONYCHOMYCOSIS 1 0.0002
355 IMMUNE SYSTEM DISORDER 3 0.0002
356 LIGAMENT RUPTURE 1 0.0002
357 ABDOMINAL ABSCESS 1 0.0002
358 LIMB DISCOMFORT 7 0.0002
359 THIRST 4 0.0002
360 ANAL INCONTINENCE 2 0.0002
361 SINUS CONGESTION 3 0.0002
362 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
363 ABDOMINAL HERNIA 1 0.0002
364 PERIPHERAL COLDNESS 3 0.0002
365 DISEASE COMPLICATION 1 0.0002
366 EAR DISORDER 1 0.0002
367 BRAIN NEOPLASM 2 0.0002
368 HUNGER 3 0.0002
369 APHONIA 3 0.0002
370 CARPAL TUNNEL SYNDROME 3 0.0002
371 DIARRHOEA HAEMORRHAGIC 2 0.0002
372 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
373 FLANK PAIN 2 0.0002
374 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
375 FRACTURE 4 0.0002
376 SPUTUM DISCOLOURED 2 0.0002
377 RENAL FAILURE 28 0.0002
378 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
379 HUMERUS FRACTURE 1 0.0002
380 HERNIA 4 0.0002
381 RASH VESICULAR 1 0.0002
382 LOCALISED INFECTION 5 0.0002
383 VITAMIN D DEFICIENCY 2 0.0002
384 HORMONE LEVEL ABNORMAL 1 0.0002
385 BODY TEMPERATURE DECREASED 2 0.0002
386 PANCREATIC DISORDER 1 0.0002
387 SKIN HAEMORRHAGE 3 0.0002
388 HYPERVOLAEMIA 1 0.0002
389 RENAL INJURY 6 0.0002
390 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
391 ABDOMINAL TENDERNESS 1 0.0002
392 ANEURYSM 1 0.0002
393 PROTEIN URINE PRESENT 1 0.0002
394 FLUID INTAKE REDUCED 1 0.0002
395 BONE LOSS 3 0.0002
396 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
397 PATHOLOGICAL FRACTURE 1 0.0002
398 DYSLIPIDAEMIA 1 0.0002
399 EYELID PTOSIS 2 0.0002
400 TOOTH ABSCESS 2 0.0002
401 PHLEBITIS 1 0.0002
402 ENDOCARDITIS 1 0.0002
403 THYROID DISORDER 3 0.0002
404 TOOTH LOSS 4 0.0002
405 MALABSORPTION 1 0.0002
406 PRODUCT USE COMPLAINT 3 0.0002
407 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
408 DERMATITIS ATOPIC 10 0.0002
409 HEAD INJURY 6 0.0002
410 BRONCHITIS 14 0.0002
411 ULCER 3 0.0002
412 CYSTITIS 6 0.0002
413 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
414 JOINT INJURY 4 0.0002
415 FOOD POISONING 1 0.0002
416 IRRITABLE BOWEL SYNDROME 4 0.0002
417 GINGIVITIS 1 0.0002
418 CHEILITIS 1 0.0002
419 ERYTHEMA OF EYELID 1 0.0002
420 RASH PRURITIC 10 0.0002
421 ILLNESS 19 0.0002
422 BIPOLAR DISORDER 2 0.0002
423 NORMAL NEWBORN 1 0.0002
424 ACUTE KIDNEY INJURY 28 0.0002
425 FAECALOMA 1 0.0002
426 URINARY TRACT INFECTION 31 0.0002
427 MACULAR OEDEMA 1 0.0002
428 ANGIOPATHY 1 0.0002
429 PRODUCT LEAKAGE 1 0.0002
430 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
431 MIGRAINE 17 0.0002
432 MITRAL VALVE INCOMPETENCE 2 0.0002
433 CHOLECYSTITIS ACUTE 1 0.0002
434 PERONEAL NERVE PALSY 1 0.0002
435 GENERALISED ERYTHEMA 1 0.0002
436 CARDIAC VALVE DISEASE 1 0.0002
437 EXERCISE TOLERANCE DECREASED 1 0.0002
438 URTICARIA 29 0.0002
439 ELECTROLYTE IMBALANCE 2 0.0002
440 HYPOVOLAEMIA 1 0.0002
441 NASAL CONGESTION 10 0.0002
442 PRODUCT DOSE OMISSION ISSUE 50 0.0002
443 COVID-19 PNEUMONIA 2 0.0002
444 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
445 PROTHROMBIN TIME PROLONGED 1 0.0002
446 RESPIRATORY DISORDER 5 0.0002
447 BLOOD POTASSIUM DECREASED 5 0.0002
448 BONE DISORDER 3 0.0002
449 PRESYNCOPE 4 0.0002
450 INJECTION SITE PRURITUS 11 0.0002
451 INJECTION SITE URTICARIA 4 0.0002
452 INJECTION SITE RASH 5 0.0002
453 INJECTION SITE EXTRAVASATION 2 0.0002
454 CHILLS 19 0.0002
455 PIGMENTATION DISORDER 1 0.0002
456 PHARYNGITIS 2 0.0002
457 BACTERIAL INFECTION 3 0.0002
458 HAIR COLOUR CHANGES 2 0.0002
459 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
460 ASTHMA 18 0.0002
461 DERMATITIS ALLERGIC 2 0.0002
462 HERPES ZOSTER 9 0.0002
463 LOWER LIMB FRACTURE 3 0.0002
464 PROCTALGIA 1 0.0002
465 HIP FRACTURE 5 0.0002
466 RHINORRHOEA 10 0.0002
467 INCOHERENT 1 0.0002
468 THERAPY INTERRUPTED 11 0.0002
469 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
470 SKIN DISCOLOURATION 7 0.0002
471 IMPAIRED HEALING 5 0.0002
472 WHEEZING 9 0.0002
473 LIP SWELLING 5 0.0001
474 SKIN DISORDER 5 0.0001
475 SPINAL FRACTURE 3 0.0001
476 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
477 JOINT RANGE OF MOTION DECREASED 2 0.0001
478 BREAST MASS 1 0.0001
479 COLITIS ISCHAEMIC 1 0.0001
480 POSTOPERATIVE WOUND INFECTION 1 0.0001
481 PRODUCT TASTE ABNORMAL 2 0.0001
482 PRODUCT LABEL ISSUE 1 0.0001
483 ABNORMAL LOSS OF WEIGHT 1 0.0001
484 CONTUSION 14 0.0001
485 PNEUMONIA 47 0.0001
486 RESPIRATION ABNORMAL 1 0.0001
487 JOINT EFFUSION 1 0.0001
488 ENCEPHALITIS 1 0.0001
489 EXTRASYSTOLES 1 0.0001
490 NECK PAIN 8 0.0001
491 BLISTER 8 0.0001
492 RASH 62 0.0001
493 LYMPHOPENIA 2 0.0001
494 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
495 SINUS TACHYCARDIA 2 0.0001
496 PRURITUS 54 0.0001
497 FEAR OF INJECTION 1 0.0001
498 RED BLOOD CELL COUNT DECREASED 4 0.0001
499 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
500 MOBILITY DECREASED 10 0.0001
501 IMPAIRED QUALITY OF LIFE 2 0.0001
502 CELLULITIS 7 0.0001
503 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
504 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
505 FAECES SOFT 1 0.0001
506 NEEDLE ISSUE 4 0.0001
507 INTENTIONAL UNDERDOSE 1 0.0001
508 MAJOR DEPRESSION 1 0.0001
509 BLINDNESS TRANSIENT 1 0.0001
510 LABORATORY TEST ABNORMAL 4 0.0001
511 PSYCHIATRIC SYMPTOM 1 0.0001
512 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
513 SEPSIS 15 0.0001
514 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
515 ECZEMA 7 0.0001
516 ANXIETY 38 0.0001
517 WEIGHT DECREASED 37 0.0001
518 PEMPHIGOID 1 0.0001
519 STOMATITIS 8 0.0001
520 DEVICE FAILURE 2 0.0001
521 HEART RATE INCREASED 13 0.0001
522 HIP ARTHROPLASTY 2 0.0001
523 BOWEL MOVEMENT IRREGULARITY 1 0.0001
524 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
525 HOSPITALISATION 20 0.0001
526 MUSCLE TWITCHING 3 0.0001
527 MUSCULOSKELETAL CHEST PAIN 2 0.0001
528 OEDEMA 7 0.0001
529 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
530 PELVIC FRACTURE 1 0.0001
531 THERAPY PARTIAL RESPONDER 2 0.0001
532 SLEEP DISORDER 9 0.0001
533 ABDOMINAL PAIN UPPER 26 0.0001
534 FURUNCLE 1 0.0001
535 BLOOD ALBUMIN DECREASED 1 0.0001
536 RENAL CYST 1 0.0001
537 SCIATICA 2 0.0001
538 ATRIAL FLUTTER 1 0.0001
539 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
540 MIOSIS 1 0.0001
541 INFECTION 18 0.0001
542 SENSORY LOSS 1 0.0001
543 ESCHERICHIA INFECTION 1 0.0001
544 HAIR DISORDER 1 0.0001
545 PHOTOSENSITIVITY REACTION 2 0.0001
546 MUSCLE INJURY 1 0.0001
547 BACK PAIN 28 0.0001
548 POLLAKIURIA 5 0.0001
549 LIVE BIRTH 1 0.0001
550 BLOOD UREA INCREASED 2 0.0001
551 CONSTIPATION 26 0.0001
552 PAIN 73 0.0001
553 CANDIDA INFECTION 2 0.0001
554 CATARACT 7 0.0001
555 SWELLING 11 0.0001
556 FALL 39 0.0001
557 PRODUCT CONTAINER ISSUE 1 0.0001
558 PSEUDOMONAS INFECTION 1 0.0001
559 SKIN ULCER 3 0.0001
560 PSYCHOLOGICAL TRAUMA 1 0.0001
561 MUSCLE STRAIN 1 0.0001
562 CARDIAC MURMUR 1 0.0001
563 MENTAL DISORDER 5 0.0001
564 RASH MACULAR 4 0.0001
565 GRIP STRENGTH DECREASED 1 0.0001
566 RESPIRATORY RATE INCREASED 1 0.0001
567 SEIZURE 13 0.0001
568 GALLBLADDER DISORDER 2 0.0001
569 FACIAL PAIN 1 0.0001
570 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
571 THROAT IRRITATION 5 0.0001
572 BLOOD PRESSURE INCREASED 17 0.0001
573 FREQUENT BOWEL MOVEMENTS 3 0.0001
574 THROAT TIGHTNESS 3 0.0001
575 OROPHARYNGEAL DISCOMFORT 1 0.0001
576 TOOTHACHE 2 0.0001
577 OSTEOMYELITIS 2 0.0001
578 PELVIC PAIN 2 0.0001
579 SKIN LESION 3 0.0001
580 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
581 NEPHROLITHIASIS 5 0.0001
582 PNEUMONIA BACTERIAL 1 0.0001
583 RESPIRATORY DISTRESS 3 0.0001
584 INCREASED TENDENCY TO BRUISE 1 0.0001
585 ABNORMAL DREAMS 3 0.0001
586 VOMITING 51 0.0001
587 NERVE COMPRESSION 1 0.0001
588 DIVERTICULITIS 3 0.0001
589 FEELING COLD 3 0.0001
590 DECREASED APPETITE 25 0.0001
591 WOUND 3 0.0001
592 OXYGEN SATURATION DECREASED 6 0.0001
593 EYE PAIN 6 0.0001
594 DYSPNOEA EXERTIONAL 4 0.0001
595 INTESTINAL OBSTRUCTION 4 0.0001
596 LEUKAEMIA 1 0.0001
597 FLATULENCE 6 0.0001
598 HYPOCALCAEMIA 2 0.0001
599 ABDOMINAL DISTENSION 11 0.0001
600 BLOOD URINE PRESENT 2 0.0001
601 INTENTIONAL DOSE OMISSION 3 0.0001
602 EYE INFLAMMATION 1 0.0001
603 PRODUCTIVE COUGH 5 0.0001
604 HYPERSOMNIA 3 0.0001
605 GAIT DISTURBANCE 20 0.0001
606 POST PROCEDURAL COMPLICATION 2 0.0001
607 BLOOD GLUCOSE DECREASED 5 0.0001
608 ACUTE RESPIRATORY FAILURE 2 0.0001
609 ATELECTASIS 1 0.0001
610 COUGH 29 0.0001
611 DIZZINESS POSTURAL 1 0.0001
612 EAR PAIN 2 0.0001
613 PARKINSONISM 1 0.0001
614 PHARYNGEAL SWELLING 1 0.0001
615 RENAL TUBULAR NECROSIS 1 0.0001
616 COELIAC DISEASE 1 0.0001
617 HEPATOMEGALY 1 0.0001
618 HOSPICE CARE 1 0.0001
619 BLADDER DISORDER 1 0.0001
620 INABILITY TO AFFORD MEDICATION 1 0.0001
621 GASTROINTESTINAL DISORDER 9 0.0001
622 HYPOTONIA 1 0.0001
623 BURNING SENSATION 7 0.0001
624 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
625 LACRIMATION INCREASED 3 0.0001
626 FULL BLOOD COUNT DECREASED 2 0.0001
627 PRODUCT PHYSICAL ISSUE 2 0.0001
628 EMPHYSEMA 1 0.0001
629 DRUG LEVEL DECREASED 1 0.0001
630 BODY TEMPERATURE INCREASED 2 0.0001
631 NASOPHARYNGITIS 18 0.0001
632 EUPHORIC MOOD 1 0.0001
633 DIARRHOEA 63 0.0001
634 INITIAL INSOMNIA 1 0.0001
635 PRODUCT PREPARATION ERROR 2 0.0001
636 HELICOBACTER INFECTION 1 0.0001
637 HYPERSENSITIVITY 18 0.0001
638 POOR VENOUS ACCESS 1 0.0001
639 EYE DISCHARGE 1 0.0001
640 NERVOUSNESS 5 0.0001
641 ROAD TRAFFIC ACCIDENT 4 0.0001
642 PRODUCT ODOUR ABNORMAL 1 0.0001
643 DERMATITIS 2 0.0001
644 ABDOMINAL DISCOMFORT 16 0.0001
645 DYSPHAGIA 9 0.0001
646 INCONTINENCE 1 0.0001
647 ABDOMINAL PAIN 22 0.0001
648 FULL BLOOD COUNT ABNORMAL 1 0.0001
649 EATING DISORDER 2 0.0001
650 RETCHING 2 0.0001
651 BREAST PAIN 1 0.0001
652 BODY HEIGHT DECREASED 1 0.0001
653 UNEVALUABLE EVENT 7 0.0001
654 HEADACHE 58 0.0001
655 FATIGUE 72 0.0001
656 AMNESIA 6 0.0001
657 BACK INJURY 1 0.0001
658 PRODUCT DOSE OMISSION 6 0.0001
659 PRODUCT DISPENSING ERROR 2 0.0001
660 PRODUCT PRESCRIBING ISSUE 2 0.0001
661 PULMONARY THROMBOSIS 1 0.0001
662 OSTEONECROSIS 3 0.0001
663 PERIPHERAL SWELLING 14 0.0001
664 INJECTION SITE NODULE 1 0.0001
665 ANAPHYLACTIC REACTION 5 0.0001
666 LIVER DISORDER 4 0.0001
667 DEHYDRATION 12 0.0001
668 STEVENS-JOHNSON SYNDROME 2 0.0001
669 HYPERTENSIVE CRISIS 1 0.0001
670 GAIT INABILITY 3 0.0001
671 INTESTINAL PERFORATION 1 0.0001
672 BLOOD CALCIUM DECREASED 1 0.0001
673 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
674 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
675 FEELING ABNORMAL 21 0.0001
676 MICTURITION URGENCY 1 0.0001
677 CHOLECYSTECTOMY 1 0.0001
678 INTERNAL HAEMORRHAGE 1 0.0001
679 TINNITUS 4 0.0001
680 MADAROSIS 1 0.0001
681 EYELID OEDEMA 1 0.0001
682 BONE PAIN 5 0.0001
683 SURGERY 5 0.0001
684 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
685 NAUSEA 67 0.0001
686 BLOOD IRON DECREASED 1 0.0001
687 RASH ERYTHEMATOUS 4 0.0001
688 NOCTURIA 1 0.0001
689 SCHIZOPHRENIA 1 0.0001
690 NEURALGIA 2 0.0001
691 DISCOMFORT 5 0.0001
692 PAIN IN EXTREMITY 24 0.0001
693 ABNORMAL WEIGHT GAIN 1 0.0001
694 INJECTION SITE DISCOLOURATION 1 0.0001
695 AGGRESSION 4 0.0001
696 ASTHENIA 30 0.0001
697 DYSARTHRIA 3 0.0001
698 ABDOMINAL PAIN LOWER 2 0.0001
699 MUSCLE ATROPHY 1 0.0001
700 DIABETES MELLITUS 6 0.0001
701 INJECTION SITE SWELLING 6 0.0001
702 CHEST DISCOMFORT 8 0.0001
703 GENITAL HAEMORRHAGE 1 0.0001
704 MALAISE 34 0.0001
705 EXPOSURE VIA SKIN CONTACT 2 0.0001
706 INJECTION SITE INDURATION 1 0.0001
707 DIPLOPIA 2 0.0001
708 ALOPECIA 15 0.0001
709 SEDATION 2 0.0001
710 INCORRECT PRODUCT STORAGE 1 0.0001
711 HYPERTENSION 16 0.0001
712 ADVERSE REACTION 1 0.0001
713 INJECTION SITE BRUISING 6 0.0001
714 PYREXIA 26 0.0001
715 DRY SKIN 10 0.0001
716 NEOPLASM MALIGNANT 5 0.0001
717 CARDIAC DISORDER 7 0.0001
718 HAIR TEXTURE ABNORMAL 1 0.0001
719 DEPRESSION 17 0.0001
720 MALIGNANT MELANOMA 1 0.0001
721 THROMBOSIS 6 0.0001
722 DYSKINESIA 3 0.0001
723 PNEUMONITIS 2 0.0001
724 AKATHISIA 1 0.0001
725 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
726 MEMORY IMPAIRMENT 10 0.0001
727 DIZZINESS 36 0.0001
728 PROCEDURAL PAIN 2 0.0001
729 MENTAL STATUS CHANGES 2 0.0001
730 DEMENTIA 2 0.0001
731 WEIGHT INCREASED 16 0.0001
732 RENAL IMPAIRMENT 6 0.0001
733 SKIN EXFOLIATION 6 0.0001
734 OSTEOARTHRITIS 3 0.0001
735 PAIN IN JAW 2 0.0001
736 MUSCULAR WEAKNESS 8 0.0001
737 HYPERHIDROSIS 9 0.0001
738 PARALYSIS 1 0.0001
739 SOMNOLENCE 14 0.0001
740 LETHARGY 4 0.0001
741 BALANCE DISORDER 6 0.0001
742 ANOSMIA 1 0.0001
743 HYPOKINESIA 1 0.0001
744 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
745 MUSCULOSKELETAL STIFFNESS 6 0.0001
746 DYSPHONIA 4 0.0001
747 PALPITATIONS 8 0.0001
748 ERYTHEMA 14 0.0001
749 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
750 ADVERSE DRUG REACTION 6 0.0001
751 THERAPY NON-RESPONDER 3 0.0001
752 APHASIA 2 0.0001
753 BLOOD COUNT ABNORMAL 1 0.0001
754 VISION BLURRED 9 0.0001
755 DRUG DISPENSING ERROR 1 0.0001
756 FEELING HOT 4 0.0001
757 PHARYNGEAL OEDEMA 1 0.0001
758 DEVICE RELATED INFECTION 1 0.0001
759 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
760 INJECTION SITE ERYTHEMA 8 0.0001
761 RENAL DISORDER 3 0.0001
762 DELUSION 1 0.0001
763 LUNG INFECTION 1 0.0001
764 BASAL CELL CARCINOMA 1 0.0001
765 BRAIN FOG 1 0.0001
766 ARTHRITIS 5 0.0001
767 OCULAR HYPERAEMIA 3 0.0001
768 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
769 NEUROPATHY PERIPHERAL 6 0.0001
770 PNEUMOTHORAX 1 0.0001
771 RESPIRATORY TRACT CONGESTION 1 0.0001
772 HALLUCINATION, AUDITORY 1 0.0001
773 PREMATURE DELIVERY 1 0.0001
774 OBESITY 1 0.0001
775 MOOD SWINGS 2 0.0001
776 ABSCESS 1 0.0001
777 SENSORY DISTURBANCE 1 0.0001
778 CARDIAC FAILURE 5 0.0001
779 SWELLING FACE 4 0.0001
780 INCORRECT DOSE ADMINISTERED 14 0.0001
781 BLOOD CREATININE INCREASED 4 0.0001
782 EYE DISORDER 2 0.0001
783 TREMOR 10 0.0001
784 BLOOD PRESSURE DECREASED 4 0.0001
785 CYTOMEGALOVIRUS INFECTION 1 0.0001
786 DYSPNOEA 34 0.0001
787 COAGULOPATHY 1 0.0001
788 FUNGAL INFECTION 2 0.0001
789 MUSCLE SPASMS 11 0.0001
790 CHEST PAIN 11 0.0001
791 FACE OEDEMA 1 0.0001
792 ANGER 2 0.0001
793 FLUID RETENTION 3 0.0001
794 HEPATIC ENZYME INCREASED 4 0.0001
795 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
796 SCAR 1 0.0001
797 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
798 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
799 JOINT SWELLING 7 0.0001
800 NIGHTMARE 2 0.0001
801 OEDEMA PERIPHERAL 7 0.0001
802 SPEECH DISORDER 3 0.0001
803 NEUROTOXICITY 1 0.0001
804 HEART RATE DECREASED 2 0.0001
805 METASTASES TO LIVER 1 0.0001
806 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
807 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
808 DRUG ERUPTION 1 0.0001
809 TACHYCARDIA 5 0.0001
810 DEVICE ISSUE 5 0.0001
811 GOUT 1 0.0001
812 ARTHRALGIA 23 0.0001
813 CRYING 2 0.0001
814 SUICIDAL IDEATION 5 0.0001
815 INJECTION SITE MASS 2 0.0001
816 EYE SWELLING 2 0.0001
817 HEPATIC STEATOSIS 1 0.0001
818 BREAST CANCER 5 0.0001
819 MIDDLE INSOMNIA 1 0.0001
820 EPISTAXIS 4 0.0001
821 PRODUCT USE ISSUE 10 0.0001
822 BLOOD SODIUM DECREASED 1 0.0001
823 PROTEINURIA 1 0.0001
824 MUSCULOSKELETAL DISORDER 1 0.0001
825 FEELING JITTERY 1 0.0001
826 INJECTION SITE PAIN 16 0.0001
827 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
828 EYE IRRITATION 3 0.0001
829 PRESCRIBED OVERDOSE 1 0.0001
830 DYSTONIA 1 0.0001
831 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
832 HAEMORRHOIDS 1 0.0001
833 PLASMA CELL MYELOMA 2 0.0001
834 ORAL HERPES 1 0.0001
835 DYSPEPSIA 5 0.0001
836 DISABILITY 1 0.0001
837 DISORIENTATION 2 0.0001
838 BLOOD PRESSURE ABNORMAL 1 0.0001
839 INJECTION SITE HAEMORRHAGE 4 0.0001
840 SYNCOPE 5 0.0000
841 PREGNANCY 1 0.0000
842 CYTOKINE RELEASE SYNDROME 1 0.0000
843 EXTRA DOSE ADMINISTERED 2 0.0000
844 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
845 INJURY ASSOCIATED WITH DEVICE 1 0.0000
846 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
847 INSOMNIA 13 0.0000
848 INJECTION SITE WARMTH 1 0.0000
849 PERITONITIS 1 0.0000
850 PULMONARY HYPERTENSION 1 0.0000
851 HAEMORRHAGE 5 0.0000
852 WITHDRAWAL SYNDROME 2 0.0000
853 KNEE ARTHROPLASTY 1 0.0000
854 CEREBROVASCULAR ACCIDENT 8 0.0000
855 ANAEMIA 9 0.0000
856 PLATELET COUNT DECREASED 5 0.0000
857 LOSS OF CONSCIOUSNESS 6 0.0000
858 IMPAIRED WORK ABILITY 1 0.0000
859 PRURITUS GENERALISED 1 0.0000
860 FAECES DISCOLOURED 1 0.0000
861 PSORIASIS 6 0.0000
862 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
863 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
864 OFF LABEL USE 40 0.0000
865 MELAENA 1 0.0000
866 ANGIOEDEMA 2 0.0000
867 COLITIS ULCERATIVE 2 0.0000
868 PULMONARY OEDEMA 2 0.0000
869 ORAL PAIN 1 0.0000
870 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
871 CHROMATURIA 1 0.0000
872 HEART RATE IRREGULAR 1 0.0000
873 APPLICATION SITE PRURITUS 1 0.0000
874 PRODUCT AVAILABILITY ISSUE 1 0.0000
875 PERICARDIAL EFFUSION 1 0.0000
876 OROPHARYNGEAL PAIN 4 0.0000
877 BLOOD CHOLESTEROL INCREASED 2 0.0000
878 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
879 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
880 CONDITION AGGRAVATED 13 0.0000
881 INJURY 3 0.0000
882 BLOOD PRESSURE FLUCTUATION 1 0.0000
883 RESPIRATORY FAILURE 3 0.0000
884 AGITATION 3 0.0000
885 DYSGEUSIA 3 0.0000
886 AGEUSIA 1 0.0000
887 HYPOAESTHESIA 6 0.0000
888 DRY EYE 2 0.0000
889 PNEUMONIA ASPIRATION 1 0.0000
890 HYPOTENSION 8 0.0000
891 HALLUCINATION 3 0.0000
892 HAEMATEMESIS 1 0.0000
893 HYPOPHAGIA 1 0.0000
894 DRUG RESISTANCE 1 0.0000
895 RASH GENERALISED 1 0.0000
896 DEATH 33 0.0000
897 DEAFNESS 1 0.0000
898 GASTRITIS 1 0.0000
899 DRUG INTERACTION 6 0.0000
900 MENSTRUATION IRREGULAR 1 0.0000
901 FEAR 1 0.0000
902 DRUG EFFECT DECREASED 2 0.0000
903 CONFUSIONAL STATE 6 0.0000
904 BLOOD BILIRUBIN INCREASED 1 0.0000
905 NEUTROPENIA 5 0.0000
906 PALLOR 1 0.0000
907 INFLUENZA LIKE ILLNESS 3 0.0000
908 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
909 ARTHROPATHY 2 0.0000
910 HAEMOPTYSIS 1 0.0000
911 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
912 ANGINA PECTORIS 1 0.0000
913 PANCREATIC CARCINOMA 1 0.0000
914 PRODUCT STORAGE ERROR 3 0.0000
915 ASCITES 1 0.0000
916 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
917 EMOTIONAL DISORDER 1 0.0000
918 VISUAL IMPAIRMENT 4 0.0000
919 EXPOSURE DURING PREGNANCY 2 0.0000
920 NERVOUS SYSTEM DISORDER 1 0.0000
921 HYPOTHYROIDISM 1 0.0000
922 MOVEMENT DISORDER 1 0.0000
923 DRUG DEPENDENCE 5 0.0000
924 EXPIRED PRODUCT ADMINISTERED 1 0.0000
925 EYE PRURITUS 1 0.0000
926 FLUSHING 3 0.0000
927 PRODUCT QUALITY ISSUE 4 0.0000
928 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
929 DEVICE USE ERROR 1 0.0000
930 NEOPLASM PROGRESSION 1 0.0000
931 HYPERKALAEMIA 1 0.0000
932 DEVICE MALFUNCTION 2 0.0000
933 LYMPHADENOPATHY 1 0.0000
934 CEREBRAL HAEMORRHAGE 1 0.0000
935 SKIN BURNING SENSATION 2 0.0000
936 C-REACTIVE PROTEIN INCREASED 1 0.0000
937 HYPERGLYCAEMIA 1 0.0000
938 PANIC ATTACK 1 0.0000
939 RESTLESSNESS 1 0.0000
940 DYSURIA 1 0.0000
941 HOT FLUSH 2 0.0000
942 COLITIS 1 0.0000
943 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
944 DRUG DOSE OMISSION BY DEVICE 2 0.0000
945 PARAESTHESIA 4 0.0000
946 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
947 ABORTION SPONTANEOUS 1 0.0000
948 CARDIAC FAILURE CONGESTIVE 2 0.0000
949 PSORIATIC ARTHROPATHY 1 0.0000
950 DEVICE BREAKAGE 1 0.0000
951 BLINDNESS 1 0.0000
952 DRUG INEFFECTIVE 32 0.0000
953 RHABDOMYOLYSIS 1 0.0000
954 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
955 HYPOACUSIS 1 0.0000
956 DEVICE LEAKAGE 1 0.0000
957 DEVICE DISLOCATION 1 0.0000
958 SEPTIC SHOCK 1 0.0000
959 DRUG WITHDRAWAL SYNDROME 2 0.0000
960 NO ADVERSE EVENT 4 0.0000
961 ADVERSE EVENT 2 0.0000
962 HYPOKALAEMIA 1 0.0000
963 BLOOD GLUCOSE INCREASED 4 0.0000
964 DRUG INTOLERANCE 2 0.0000
965 HYPOGLYCAEMIA 1 0.0000
966 MUSCULOSKELETAL PAIN 1 0.0000
967 DEPRESSED MOOD 1 0.0000
968 BRADYCARDIA 1 0.0000
969 DRUG DOSE OMISSION 3 0.0000
970 HAEMATOCHEZIA 1 0.0000
971 TOXICITY TO VARIOUS AGENTS 3 0.0000
972 HYPONATRAEMIA 1 0.0000
973 MYALGIA 3 0.0000
974 RHEUMATOID ARTHRITIS 2 0.0000
975 PRODUCT SUBSTITUTION ISSUE 1 0.0000
976 MYOCARDIAL INFARCTION 3 0.0000
977 BLADDER CANCER 1 0.0000
978 IRRITABILITY 1 0.0000
979 DEVICE EXPULSION 1 0.0000
980 DEEP VEIN THROMBOSIS 1 0.0000
981 DEVICE DIFFICULT TO USE 1 0.0000
982 INJECTION SITE REACTION 1 0.0000
983 PROSTATE CANCER 1 0.0000
984 INTENTIONAL PRODUCT MISUSE 1 0.0000
985 PULMONARY EMBOLISM 1 0.0000
986 ATRIAL FIBRILLATION 1 0.0000
987 OVERDOSE 2 0.0000
988 DISEASE PROGRESSION 1 0.0000